Potential neuroprotective strategies for perinatal infection and inflammation

Int J Dev Neurosci. 2015 Oct:45:44-54. doi: 10.1016/j.ijdevneu.2015.02.006. Epub 2015 Feb 19.

Abstract

Preterm born infants have high rates of brain injury, leading to motor and neurocognitive problems in later life. Infection and resulting inflammation of the fetus and newborn are highly associated with these disabilities. However, there are no established neuroprotective therapies. Microglial activation and expression of many cytokines play a key role in normal brain function and development, as well as being deleterious. Thus, treatment must achieve a delicate balance between possible beneficial and harmful effects. In this review, we discuss potential neuroprotective strategies targeting systemic infection or the resulting systemic and central inflammatory responses. We highlight the central importance of timing of treatment and the critical lack of studies of delayed treatment of infection/inflammation.

Keywords: Brain injury; Cytokines; Infection; Inflammation; Lipopolysaccharide; Perinatal; White matter.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Brain / physiopathology
  • Brain Injuries / diagnosis
  • Brain Injuries / physiopathology*
  • Brain Injuries / prevention & control*
  • Central Nervous System Infections / diagnosis
  • Central Nervous System Infections / physiopathology*
  • Central Nervous System Infections / prevention & control*
  • Encephalitis / diagnosis
  • Encephalitis / physiopathology*
  • Encephalitis / prevention & control*
  • Evidence-Based Medicine
  • Female
  • Humans
  • Infant, Newborn
  • Male
  • Neuroprotective Agents / therapeutic use
  • Treatment Outcome

Substances

  • Neuroprotective Agents